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Health is a key component of the human development index. This paper looks at how health is 
measured, how the level of health across countries is converging, and which countries are 
outliers to this global trend. We argue that conceptually health measures should account for 
illness as well as mortality. However, in practice we show that population mortality and illness 
measures tend to move closely together, allowing us to use life expectancy as a reasonable proxy 
for population health.   
 
Overall health is improving, and over the last 40 years life expectancy has been converging, with 
larger gains taking place in countries that initially had lower levels of life expectancy. We show, 
however, that a detailed analysis gives a more complex picture. Rather than a long term pattern 
of global convergence we see two distinct groups of countries in the data, clustering around 
different long run levels of life expectancy.    
 
We consider outliers from the general picture found in cross-country analysis. HIV/AIDS plays a 
large role in explaining the poor health performance of some countries particularly in Sub-
Saharan Africa. HIV/AIDS has meant that from 1990 on the process of convergence in health 
has stopped and is being reversed.  
 
Finally we argue that health improvements do not have to wait for national income to rise. Many 
countries have experienced large health gains without prior income gains, and in countries not 
affected by HIV/AIDS the last 40 years have largely been a success story in terms of 
achievements in health. 
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The Human Development Research Paper (HDRP) Series is a medium for sharing recent 
research commissioned to inform the global Human Development Report, which is published 
annually, and further research in the field of human development. The HDRP Series is a quick-
disseminating, informal publication whose titles could subsequently be revised for publication as 
articles in professional journals or chapters in books. The authors include leading academics and 
practitioners from around the world, as well as UNDP researchers. The findings, interpretations 
and conclusions are strictly those of the authors and do not necessarily represent the views of 
UNDP or United Nations Member States. Moreover, the data may not be consistent with that 
presented in Human Development Reports. 1 
 
1.  Health in Human Development 
There is wide spread agreement that heath is an important component of human 
development. Health was identified as a component of human development in the Human 
Development Report 1990 (United Nations Development Program 1991) and is a central part of 
the Human Development Index. The World Bank has shifted from an emphasis on promoting 
economic growth (e.g. Commission on International Development, 1969) to include a focus on 
health, education, and social exclusion (see World Development Report 2001). The Millennium 
Development Goals, adopted at the Millennium Summit of the United Nations in September 
2000 focused on poverty, mortality, education, health, gender equality and environment as the 
key measures of development.   
  More recently The Commission on the Measurement of Economic Performance and 
Social Progress  (2009) put forward eight distinct spheres of wellbeing in addition to 
consumption and wealth: health, education, personal activity, political voice and governance, 
social connectedness, environmental conditions, personal insecurity, and economic insecurity. It 
also argued for a focus on inequality in these indicators as well measures of their average levels.  
  While there seems to be general agreement that health is an important component of 
human development there is an issue about how exactly we should measure health. To some 
extent this is a question of the conceptual underpinning of the development measure we seek. 
Our theory of what development is, and of well being, should dictate the appropriate health 
measure.  On the other hand we have the consideration that at present we only have few 
internationally comparable measures of health and in practice must base comparisons on these. 
While it is true we are limited in the set of health variables we can use, it is useful to discuss how 2 
 
well these measures correlate with the more meaningful underlying measure of health we would 
like to use.    
This gap between theory and measurement is partly a matter of a conceptual gap – the 
health measure we use may be trying to measure something that is different for the measure we 
would wish in theory. However we also have measurement error; we may not perfectly capture 
the construct we are trying to capture. 
  The measure of health currently used in the Human Development Index is life 
expectancy. The period 1970-2005 has seen large improvements in life expectancy in most 
countries and convergence in life expectancy, with countries that had lower life expectancy in 
1970 seeing larger gains in life expectancy subsequently.  However, when we look at the data in 
more detail a more complex picture emerges. Instead of uniform convergence to a high level of 
life expectancy, there appear to be two separate groups of countries. One group has low life 
expectancy while the other has high life expectancy. Among the high life expectancy countries 
we see modest and fairly uniform gains in life expectancy over time. Among countries with low 
initial life expectancy increases in life expectancy are not a uniform and smooth catch up. Rather 
some countries that initially have low life expectancy seem to jump to join the high life 
expectancy regime, while others stagnate with low or little in the way of life expectancy gain, 
and sometimes even falling life expectancy. 
  As well as the general trends outlines above we have some countries which are outliers to 
the process. One set of outliers are the Sub-Saharan African countries with high levels of 
HIV/AIDS.  The general patterns of pattern relative failure of countries with initially low life 
expectancy is exacerbated by the large number of HIV/AIDS deaths in Sub-Saharan but the 
phenomenon is not entirely due to HIV/AIDS; these countries are outliers to the process outlined 3 
 
above.  The countries with high prevalence rates of HIV have seen little in life expectancy 
improvement and indeed some have seen absolute declines relative to 1970 levels.  The other 
area in which there has been a relative failure to improve life expectancy has been in the former 
Soviet Republics. In contrast to these we have a number of success stories, countries with life 
expectancy gains far in excess of our model’s predictions and sometimes involving a jump to 
low level health regime to the high level regime.     
  We also discuss the interrelationship between health and income. Income per capita is 
also part of the human development index and across countries higher levels of health and 
income go together. However the relationship is not close enough to take one as a proxy measure 
of the other. In addition, over the years 1970-2005 we see much larger improvements in health 
around the world than we would expect based solely on the increases in income over the period. 
Countries, even very poor countries, can improve their population health using direct health 
interventions even when incomes are not rising. It is important to realize that health 
improvements can be achieved with first waiting for income to rise.   
  Overall we have a fairly good picture of achievement in health. In most countries life 
expectancy has risen and the relatively faster rise in countries with initially low levels of health 
means that in these countries their human development index, relative to the leading country, 
will be rising.  The great worry is the health crisis, particularly in Sub-Saharan Africa, being 
brought about by the high prevalence of HIV/AIDS. This is undoing significant gains that were 
being made up until 1990 and makes it difficult to see substantial health gains in these countries 




2. The concept of health  
  Life expectancy is the health measure used in the Human Development Index. We begin 
by considering the issue of whether life expectancy is the right measure of population health on 
conceptual grounds. Mathers et al. (2003) also consider this issue.  It is clear that a longer life 
span is preferable to a shorter lifespan, but the quantity of lifespan says nothing about the quality 
of life. There are a number of approaches to adjusting life years lived by health status to get a 
better measure that accounts for illness. One approach is to use quality adjusted life years 
(QALYs) where individuals express the their preferences by valuing a the quality of a life year 
lived in a state of ill health as the fraction of a year lived in full health that would give them the 
same utility.  Another is to use disability adjusted life years (DALYs) where a life year lived 
with disability is considered equal to a fraction of a year lived in full health, with the adjustment 
being made by an expert panel.  
  To some extent these two approaches to adjusting life years for ill health represent 
different ways of thinking about of welfare. One way is to use a utilitarian social welfare 
function. In this approach social welfare is defined as the sum of individual utilities.  In a utility 
approach the right way to weight goods is in terms of individuals’ willingness to trade them off 
for other things, depending on how much they add to utility. This leads to using QALYs.    
However, in the capabilities approach to measuring development we can think of welfare as 
being measured by the size of the choice set rather than the utility of what is chosen.   In the 
capabilities approach we can think of healthy life span as a basic constraint that limits people's 
choice, and we want to measure the objective size of the choice set, independently of how people 
value the choices. This approach leads to a preference to use DALYs. 5 
 
  A related issue is that QALYs depend on individual tradeoffs and the estimated QALY 
adjustment for a particular disability may vary between countries. If this is the case two countries 
with the same level of disability may have different estimates of their health status if people in 
the two countries value a year of life lived in disability (in terms of life years lived in full health) 
differently. It seems undesirable that countries with the same objective measures of health should 
be ranked differently in terms of welfare because of different preferences; we should therefore 
establish worldwide average values of the QALY adjustment related to each disability. This is 
difficult to do, and requires widespread surveys of preferences, while DALY adjustments have 
been already been set for each disability.     
  In order to get a single measure of population health including ill health as well as death, 
we can calculate healthy life expectancy, weighting years lived in disability as a fraction of a 
year lived in full health, using the DALY approach. To do this we need data on mortality and 
also the prevalence of disease and the frequency of each type of disability associated with each 
disease as well as DALY weights for each disability.  Figure 1 plots estimates of life expectancy 
against healthy life expectancy for 192 countries in 2002 using data from the World Health 
Report 2004 (World Health Organization 2004). We see a very close association between the 
two measures, with healthy life expectancy rising linearly with life expectancy.    A regression of 
healthy life expectancy, HL, on life expectancy, L, using this data gives 
 
2
HL =-3.859 + 0.936 L
(0.424) (0.006)
192 R 0.991 N = =
 
where we have standard errors of the estimates in parentheses.  6 
 
  The intercept is significantly different from zero and the coefficient on life expectancy is 
significantly lower than one. This implies that healthy life expectancy is not simply a proportion 
of life expectancy. For example, according to this linear relationship, when life expectancy is 40, 
then healthy life expectancy is 33.6 and the proportion of years in ill health is 0.16. In contrast, 
when life expectancy is 70 then healthy life expectancy is 61.6 so the proportion of years in ill 
health is 0.12. Figure 2 shows that the fraction of life spent in disability is relatively constant 
across countries with life expectancy below 60, but for countries where life expectancy is above 
60 years the proportion of years in disability appears to decline as life expectancy rises.  
  In Figure 3we plot the expected years in disability against life expectancy. This shows 
that people living in countries with higher life expectancy expect more years of disability, up to a 
life expectancy of about 70. For life expectancies above 70 however, increased life expectancy 
seems to be associated with and lower number of years lived with disability. It appears that at 
low levels of health, as health improves, in terms of longer life spans, the onset of disability is 
also pushed back proportionately, so that the fraction of life spent in disability stays relatively 
constant. However at very high levels of life expectancy we see a “compression of morbidity”, 
longer life spans are associated with a compression of the number of years spent disabled.    
  In most developed countries we have time series data showing this compression of 
morbidity (Fries, 2003). When life expectancy increases, healthy life expectancy increases more 
than proportionately, compressing  the number of years lived with disability into a shorter 
fraction of the lifespan. This means that life expectancy increases in developed countries are 
generally very good news since they go hand in hand with greater healthy life expectancy and 
delays in the average age at which disability occurs. Unfortunately we lack similar time series 
evidence on how expected years in disability changes when life expectancy increases in 7 
 
developing countries. The cross-country evidence, shown in Figures 2 and 3, points to the 
expected age of onset of disability rising proportionately with life expectancy in these countries 
making life expectancy a fairly good proxy for healthy life expectancy. 
  In cost effectiveness studies in which health gains are measured in QALYs or DALYs we 
usually discount gains to future life expectancy by a social discount rate (often a rate of 3% per 
annum is used).  We could apply the same logic to measures of life expectancy at birth and argue 
that survival at birth, which comes in the immediate future, is more valuable than survival at 
older ages which comes in the distant future.  However discounting in this way has several 
problems. Firstly we may not want to discount health at the same rate as money, and secondly it 
is it unclear that the discount rate used by individuals in deciding  between present and future 
consumption is appropriate as social discount rate for comparing across generations born at 
different times (see Kaplow 2007 for a discussion of these issues).  
  In addition, life expectancy is not measured for a cohort born today over its future. It is 
actually a synthetic measure constructed from current period age specific mortality rates, and is 
the life span a person would one would expect if they were exposed to this age specific mortality. 
If we think of life expectancy simply as a summary statistic, capturing current age specific 
mortality rates in a single number, there is no need to discount.   However thinking of it as a 
summary measure of current mortality rates does raise the issue that it is more sensitive to 
changes in the infant mortality rate than to changes in mortality at older ages, since the "cost" of 
a death in terms of life expectancy foregone declines with age (Vaupel 1986).   
  There is also the issue of inequality in life spans. A particular level of life expectancy can 
represent very different age specific mortality patterns. For example, in one country everyone 
could live to age 70 while in another half the people could live to age 50 and the other half to age 8 
 
90.  Both these populations will have life expectancy 70, on average, but one has equal life spans 
while the other has very unequal life spans. We could think of the variation in life spans as 
undesirable inequality if different life spans are identified with different groups in the population. 
Alternatively if everyone has the same life expectancy the different life spans actually 
experienced could be viewed as undesirable risk (Edwards, 2008).  In either case we might want 
a measure that considered not just life expectancy but also the spread of life span outcomes 
experienced by the population. Penalizing the spread of life span outcomes introduces something 
that looks very like time discounting since gains in life span at high levels of life span are less 
valuable than gains at low spans, though now the "discount rate" can be thought of as a measure 
of social aversion to inequality or a measure of risk aversion.  However, it should be noted that 
the issues of inequality and risk cannot really be dealt with in one dimension of wellbeing alone. 
When we consider inequality and risk we will be concerned with the joint distribution of health, 
income and education, since the welfare impact of deprivation are unlikely to be simply additive. 
  In addition to the issue of getting the right measure of health there is the issue of how 
health should be weighted in constructing the human development index.  At present health, 
income and education get equal weights on one third each. If we take a social welfare approach 
to measuring human development we can ask how people value health improvements in terms of 
money units to get a sense of the relative importance of health and income in welfare. Becker, 
Philipson, and Soares (2005) estimate the money value of health improvements in each country 
based on estimates of willingness to pay for additional life years (Viscousi and Aldy 2003). They 
find that the value of life expectancy improvements between 1960 and 2000 were, on average, 
about the same as the value of income improvements. This implies that we should weight a 
countries health improvements roughly equally with is income improvements when thinking 9 
 
about total welfare and is in line with the current weighting of income and health in the human 
development index. 
 
3. Estimates of Life Expectancy 
   The human development index currently uses life expectancy as its measure of health. In 
this section we assume that life expectancy is the right measure and ask how well it is measured 
by current statistics. In theory, life expectancy can be calculated directly from age specific 
mortality rates. However when direct measures of age specific mortality are not available, or are 
unreliable, there are also indirect methods of estimating life expectancy.  Demographic indicators 
such as population growth rates, and the age distribution, are closely linked to mortality rates and 
life expectancy, and data on such demographic indicators can be used to make inferences on the 
level of life expectancy.  The United Nations constructs reasonable estimates of life expectancy 
that are consistent both with the direct evidence and with indirect indicators, using information 
from a variety of data sources in each country.  
Measurement of mortality rates and demographic indicators can be based on vital 
registration data, age distributions in the census, and nationally representative survey information 
on infant mortality and deaths of other family members. All of these data sources have potential 
problems, due, for example,  to under-reporting of deaths in vital registration, under-enumeration 
of the population and age misreporting in census data, and survey data may suffer from error due 
to small sample sizes.  The complete set of estimates of life expectancy across countries and over 
time includes some interpolated or extrapolated data, particularly prior to 1980 (Bos,  Vu, 
Stephens, Patience, 1992).  10 
 
The introduction of the World Fertility Surveys in the 1970s, which were followed by the 
Demographic and Health Surveys from the mid 1980s onwards, have led to improved estimates 
of infant and under five mortality in many developing countries. Data on adult mortality rates are 
often less reliable in these countries (Hill 2003). When the availability of relevant direct data are 
limited, model life tables are used to provide indirect estimates life expectancy. For example 
when there is data only on infant mortality available model life tables can be used to impute life 
expectancy. This means that life expectancy estimates for developing countries are sometimes 
based on a simple transformation of their infant  mortality rates (Deaton 2007). These 
transformations have changed over the last few years to take into account the change in age 
specific mortality pattern due to HIV/AIDS.  
  The underlying data on infant and under five mortality rates from household surveys may 
be less reliable if they are used to estimate child mortality retrospectively. While questions on 
births and child survival asked of mothers (conditional on these mothers still being alive) over 
the last five years are usually thought to be reasonable, calculating infant mortality rates on 
longer recall periods may be subject to recall bias. Issues of methods and measurement in 
estimating life expectancy are discussed in detail in Lopez et al. (2003). Even the best estimates 
are subject to a range of uncertainty and Daponte et al. (1997) discuss how to quantify this 
uncertainty. Given the imperfection of the estimates, Bayesian methods that impose some prior 
knowledge of the structure of the data may lead to improved mortality estimates; this approach is 
used by Girosi and King (2008).  
In Figure 4 we plot under five mortality rates for Guatemala. Guatemala had 
Demographic and Health Surveys (DHS) in 1987, 1995 and 1998. These surveys tell a fairly 
consistent story, rates calculated using recall in a later DHS tend to match fairly closely the rates 11 
 
found at the time in an older DHS. In addition, Guatemala has a vital registration and figures on 
under-five mortality from the registered deaths match the DHS estimates quite closely. There are 
a few very high estimates of under-five mortality in the 1960’s but these are not matched by the 
vital registration data. While the consistency of the data from different sources is encouraging it 
does not mean that the mortality estimates derived from them are correct; in principle there could 
be the same bias occurring in each source.  
In Figure 5 we plot estimates of under-five mortality based on data from Demographic 
and Health Surveys for Nigeria in 1990 and 2003 as well as mortality data from the World 
Fertility Survey (WFS) in 1981. While the data in figure 4 from different surveys agree quite 
well over time, the data for Nigeria for under-five mortality based on the three surveys differ 
markedly.  In comparing the data from the 2003 DHS survey in Nigeria with data from the 1990 
DHS survey we have the problem that when the data cover the same years they do not overlap. 
This may be due to recall bias in the later survey, or to one of the surveys not being 
representative of the overall population.  We also have the problem that the recall estimates from 
the 1990 DHS survey are generally higher than those found at the time in the 1981 World 
Fertility survey. We are left of the problem of constructing a consistent time series for infant 
mortality in Nigeria from surveys that give conflicting evidence. Given the large role that under-
five mortality rates play in determining life expectancy (Vaupel 1986) these examples 
demonstrate the type of issues that have to be addressed when constructing life expectancy 
estimates. In developed countries mortality at older ages plays a larger role in variations in life 
expectancy (White 2002). 
  These caveats on data quality mean that we should not draw too much in the way of 
inference  from small differences in estimated life expectancies. The data may however be 12 
 
sufficiently reliable to discern some broad movement in health. Until the advert of HIV/AIDS, 
infant mortality rates were falling, and life expectancy was rising worldwide, even in countries 
with little or no growth in income   (Ahmad, Lopez, & Inoue, 2000, Cutler, Deaton and Lleras-
Muney, 2006). In the following sections we shall investigate to what extent this represents 
convergence in health and what factors are driving these health gains.  
  Overall, our analysis points to some possible improvements in the measurement of health 
as a human development indicator.  Conceptually there is a strong argument for using healthy 
life expectancy, adjusting life expectancy downward for years lived with disability, as our health 
metric. However this would require a major new data collection effort to collect data on the 
prevalence of disability. The strong linear relationship shown in Figure 1  suggests that life 
expectancy, which depends only on mortality and not morbidity, may in practice capture a large 
portion the actual variation in population health. We might also consider how to improve our life 
expectancy measure to adjust for inequality, or risk, due to the variance of life span outcomes. 
There is scope for improvement in data quality, particularly in developing countries where life 
expected is often modeled based on very sparse data rather than estimated from actual age 
specific mortality rates. 
    
4. Improvement and Convergence in Life Expectancy 
The general consensus in the literature is that while income per gaps have been fairly constant 
over the last 50 years, health status is low health countries has been improving faster than in high 
health countries leading to a convergence in population health levels around the world (Deaton, 
2004) . The issue of convergence is important for the human development index since countries 13 
 
are measured relative to the leading country. Uniform improvements with no convergence will 
mean that average value of the human development index across countries will remain the same. 
However if there is convergence the average value of the index will rise as countries close with 
the leader.  
  In this section discuss three challenges to this consensus of convergence. First, the picture 
of convergence depends on which health measure we take, and is sensitive to transformation of 
the health measure. For example, log life expectancy may not be converging while life 
expectancy does converge. We show this dependence on functional transformation is 
fundamental and means we should use a conceptually correct measure of health so we are talking 
about convergence of interesting, meaningful, variables. Secondly, we show that convergence 
holds from 1970 to 1985 but since 1990 there has been large scale divergence. Thirdly, if we 
measure population health in terms of life expectancy we show that the picture is of two 
convergence clubs rather than uniform convergence over the period 1970-2005. All countries 
that had good levels of health in 1970, and some countries that had low levels, are converging 
towards a common high level of life expectancy. However there is a substantial group of 
countries, whose health status was low in 1970, that are converging together towards a much 
lower level of life expectancy  
  Health, as measured by life expectancy, has been improving in most countries over the 
last fifty years. In addition to this evidence of improvement on average, there is evidence that life 
expectancy is rising fastest in countries that had low life expectancy in 1970, leading to the view 
that life expectancy gaps between countries are narrowing, with the prospect of convergence in 
health in the long run (Deaton, 2004; Neumayer, 2003; Sab and Smith, 2002; Hobijn and Franses 
2001).   14 
 
One way to think about convergence in life expectancy is to ask if countries with lower 
initial life expectancy tend to see larger gains in life expectancy. In this case a regression of the 
change in life expectancy on the initial level of life expectancy will produce a negative 
coefficientβ on life expectancy, countries with initially low life expectancy will tend to have 
larger increases in life expectancy (this is known as β - convergence). That is, we estimate the 
model 
i ii LL αβ ε ∆=+ + 
Where  i L ∆  is the change in life expectancy and  i L is initial life expectancy. Figure 6 
shows the relationship between life expectancy in 1970 and subsequent gains in life expectancy 
over the period 1970-2005. The data we use in this section is from Molina and Purser (2010) and 
gives life expectancy for 174 countries over the period 1970-2005. 
The results, reported as model 1, in Table 1 show a simple OLS regression of the change 
in life expectancy on a constant and the initial level of life expectancy. Both Figure 6 and Table 
1 suggest that there is  β - convergence, the trend line in Figure 6 is downward sloping, and the 
estimate of β , the coefficient on initial health in 1970, is negative and statistically significant. 
A difficulty with the concept of β -  convergence is that it is not invariant to 
transformations of the data.  To show this suppose we have  
(log ) log(1 ) i L β ∆= +  15 
 
In this case log life expectancy is changing at a constant rate (1 ) β + in each county and is 
not converging, since the rate of change is independent of the initial level of log life expectancy. 
Transforming this equation we can however derive 
ii LL β ∆=  
This implies we may have no convergence in log life expectancy but rapid convergence 
in the level of life expectancy
1
An alternative approach to thinking about convergence is to consider the standard 
deviation, 
. This issue is fundamental, convergence in the level of a variable 
does not imply that every positive transform of that variable is also converging. The only 
solution is to make sure that the health measure we use is the one we are interested in from a 
welfare perspective.  
σ ,  of life expectancy across countries and ask whether this measure decreases over 
time (“σ -convergence”)
2
                                                           
1 An extreme version of this occurs with infant mortality rates. These are converging towards zero in most countries 
but the log infant mortality rates are not converging and may remain widely separated.   
. Figure 7 shows the standard deviation of life expectancy for the 174 
countries in our sample. The standard deviation of life expectancy across countries fell between 
1970 and 1985, but has risen since 1990.  This rise is mainly due to the emergence of high 
HIV/AIDS mortality in countries that already had high mortality which has lead to widening 





th percentiles of the life 
expectancy distribution between 1970 and 2005. We can see that there is substantial convergence 
between the 50
th and 90
th percentiles. However, since 1990 there have been almost no gains in 
life expectancy in the 10
th to 25
th percentiles, which is what lies behind the increasing standard 
deviation in life expectancy across countries.  
2 β -convergence is necessary, but not sufficient, for σ - convergence. 16 
 
Even if we accept the evidence of improving and converging life expectancy over the 
period 1970-2005 taken as a whole as shown in Figure 6 there is a worry that these average 
trends mask considerable variation in the experience of individual countries.  McMichael, 
McKee, Shkolnikov and Valkonen (2004) divide countries into three groups, those that have 
seen rapid improvement in life expectancy over the period, those that have seen relative 
stagnation in their life expectancy, and those that have seen sharp reversals and falling lifespan in 
recent years.  Molina and Purser (2010) show that life expectancy is converging worldwide, but 
that this convergence is much more evident if African countries are excluded from the sample.  
We argue that while, on average, countries with low life expectancy in the 1960's have 
seen the faster increases, the data tells a more complex story. Figure 9 plots the distribution of 
life expectancy in 1970 and 2005, using a kernel density estimator
3
The twin peaks in the distribution of health may represent a “mortality trap” that parallels 
the poverty trap that we see in the world income distribution.  In this view there are multiple 
. An examination of the 
distribution of life expectancy in 1970 reveals twin peaks; there are a group of countries 
clustered around a life expectancy of 45 with another group clustered around a life expectancy of 
67. By 2005 the modes of both these clusters have moved up by about 10 years.  While progress 
in both groups has been similar, a number of countries appear to have made the jump for the high 
mortality cluster to the low mortality cluster. The height of the high life expectancy cluster has 
increased while the density at the low cluster has fallen. Rather than a process of continuous 
convergence, the data suggest continuous advances within clusters, but with large advances in 
life expectancy in particular countries due to jumping between clusters. 
                                                           
3 This is, essentially, a smoothed histogram. 17 
 
equilibria. There is a trap, with low income and high mortality, but countries can escape from 
this trap and converge on the high level equilibrium with high income and low mortality. An 
alternative view is that there is a unique equilibrium for each country which depends on that 
country’s characteristics. This means some countries have characteristics that lock them into low 
mortality and high income while others have characteristics that give them high mortality and 
low income while by chance there are few countries with characteristics that give outcomes in 
between these extremes. Bloom, Canning, and Sevilla (2003) test a model where the twin peaks 
in the income distribution is due to multiple equilibria as against a model where different 
countries have different outcomes based on their characteristics, such as geography and climate. 
They find that the evidence favors multiple equilibria; countries with very similar characteristics 
can have very different outcomes. 
We now test formally a model of two convergence clubs, allowing for jumps between 
clubs, against a model where all countries are converging following the same continuous (though 
non-linear) rule. Our first model is the simple linear form we have already discussed  
 
Model 1:   
2 (0, ) i ii i L L where isdistributed N αβ ε ε σ ∆=+ +  
 
We take  i L  to be initial life expectancy in 1970 and  i L ∆  to be the change in life expectancy over 
1970-2005. A negative coefficient on initial life expectancy implies β - convergence. 
  While this model is standard in the literature it is not clear that it fits the data very well.  
In particular, looking at figure 6 we see that the largest gains in life expectancy did not occur in 18 
 
the countries that initially had the lowest life expectancy.  Rather countries near the middle of the 
initial distribution of life expectancy seem to have done best.  In addition, the appears to be much 
more variance in the performance of countries that initially had low life expectancy while the 
health gains we see in countries that had high initial life expectancy are much more tightly 
grouped.  
Consider again Figure 9 showing the distribution of life expectancy across countries 1970 
and again in 2005 using a kernel estimator.  The striking feature of these plots is the twin peaks 
in the distribution of life expectancy.  Some countries are clustered around a low level of life 
expectancy while others cluster around a high level of life expectancy, with very few countries 
being in the middle between these two clusters.  Over time, the modal life expectancy in each 
cluster has moved to the right.  However, in addition, some countries appear to have “jumped” 
from the low life expectancy cluster, reducing its height, to the high life expectancy cluster, 
increasing the size of its peak.    
Figure 9 suggests a more complex model of the evolution of life expectancy is required. 
We propose a two regime model.  In each regime there is convergence to a steady state, but these 
steady states may differ, being higher in regime 1 (the “high life expectancy” regime) than in 
regime 2 (the “mortality trap”).  Countries are more likely to be the mortality trap regime if their 
initial life expectancy is low, but there have a chance of “jumping” to the high life expectancy 
regime, with a probability that depends on their initial income level. 





11 1 1 1 (0, ) 1 i ii i i L L where isdistributed N with probability p αβ ε ε σ ∆= + + − 
2
22 2 2 2 (0, ) i ii i i L L where isdistributed N with probability p αβ ε ε σ ∆= + +  
01 () ii and p CumNorm p p L =+  
We assume that in each regime there is a linear relationship between initial life expectancy and 
the improvement in life expectancy.  This will generate β -convergence within each regime. The 
probability of being in a particular regime depends on initial life expectancy (we assume the 
likelihood is a linear function of initial life expectancy, translated to a probability by the 
cumulative normal distribution). 
  We estimate model 2 by maximum likelihood. Estimation and hypothesis testing using 
model 2 is not straight forward since the model does not satisfy the usual regularity conditions 
used in statistical modeling.  Our estimation methods require a grid search over possible 
parameter values, while hypothesis testing requires Monte Carlo methods to estimate the 
distribution of test statistics. The statistical problems of these types of models, and methods we 
can use to overcome them, are described in detail in Bloom, Canning and Sevilla (2003).   
  The results of our estimation of model 2 are shown in columns 2 and 3 of Table 1. We 
estimate two regimes each with β -convergence, but with different slopes.  The "mortality trap" 
regime gives smaller improvements in life expectancy at each level of live expectancy. Figure 10 
plots the two regimes. The results in table 1 show that the probability of being in the “mortality 
trap” regime decease as initial life expectancy rises.  Countries with life expectancy above 55 in 20 
 
1970 are almost certain to be in "high life expectancy" regime.  However, for countries with life 
expectancy below 55 in 1970 there is a probability of being in the good regime and a probability 
of remaining in the mortality trap. A likelihood ratio test (based on bootstrapped critical values) 
of the two regime model against a single regime decisively rejects a single regime; the two 
regimes fit the date better. The two regime model also fits better than a more complex single 
regime models that allows for a nonlinear relationship. 
We find that the data rejects the model in which all countries follow the same process in 
favor of the convergence club approach.  Our results include a number of countries that have 
seen substantial declines in life expectancy since 1990 due to HIV/AIDS.  However our 
conclusions do not depend on the presence of HIV/AIDS; we obtain similar results using data on 
life expectancy that exclude the effect of HIV/AIDS mortality, though in this case the 
performance of the “mortality trap” regime is not as bad as when we include AIDS mortality 
(Bloom and Canning 2007).   
   The twin peaks in the distribution of life expectancy in figure 10 are very similar to the 
twin peaks in income reported in Quah (1996). This raises the idea that development is not a 
smooth process, but involves a trap with low income and poor health. Some countries, however, 
manage to escape this trap and once they have broken free they converge quickly to the high 
level equilibrium.  This means that we see some countries clustered around the low level trap, 
while others are clustered around the high level equilibrium, with only a few countries in 
transition between the two “clubs”. 




The two regime model set out in Table 1 and shown in Figure 10 captures the overall picture of 
movements in life expectancy but some individual countries deviate from the predictions of the 
model.  In Table 2 we list the countries in our dataset in order of their life expectancy in 1970 
shown in column 1. In column 2 we show the actual gain in life expectancy in the country over 
the period 1970-2005. Column 3 shows the expected gain in the country over the period if it is in 
the “mortality trap” regime. Column 4 shows the expected gain in the high life expectancy 
regime. Column 5 gives the probability that a country is in the mortality trap regime given its life 
expectancy in 1970. Column 6 gives the probability that it is in the mortality trap regime given 
its 1970 life expectancy and the gain in life expectancy seen over the period 1970-2005. We 
calculate the posterior probability of the regime given the data on its performance over the period 
1970-2005 using Bayes’ rule.  We highlight countries in green that appear to have jumped out of 
the mortality trap over the period, while we highlight in red those who seem to have jumped 
from the high life expectancy regime into the mortality trap.  
  Four countries seem to have jumped out of the mortality trap. Indonesia, Viet Nam, 
Oman, and Maldives all had low life expectancy in 1970 and based on this, the probability we 
assigned to them being in the mortality trap in column 5 was greater than one half. However, as 
we can see each of these countries experienced a rapid increase in life expectancy over the period 
1970-2005. This rapid gain was in each case much closer to the rapid gain predicted by the high 
life expectancy regime than the mortality trap. The posterior probability of being in the mortality 
trap regime given this good performance, shown in column 6 of Table 2, is in each of the four 
cases less than one half.  22 
 
  The countries in red, Myanmar, Kenya, Namibia, South Africa, Congo, Botswana and 
Zimbabwe, all had reasonably high life expectancy in 1970 and we assign them on this basis to 
being in the high life expectancy regime (their probability of being in the mortality trap in 1970, 
shown in column 5, is less than one half). However their performance over the period 1970-2005 
was poor, indeed South Africa, Congo, Botswana and Zimbabwe all saw decreases in life 
expectancy. Given this poor performance the posterior probability they are in the mortality trap 
regime, shown in column 6, exceeds one half.  
  Considering performance relative to that predicted by the initial regime, and looking for 
jumps between regimes is just one way of thinking about outliers. In Figure 11 we plot actual 
performance against the expected change in life expectancy for each country. The expected 
change is the weighed average of the predicted change in each regime from columns 3 and 4 of 
Table 2, with the weights being the probability of the regime based initial life expectancy as 
shown in column 5. Figure 11 shows the expected gain declining with initial life expectancy 
within each regime but rising in the middle of the range of initial life expectancy due to the 
increasing probability of being in n the high life expectancy regime.  
  Table 3 lists countries together with their actual and predicted gains in life expectancy as 
shown in Figure 11. Column 4 in Table 11 gives the actual minus predicted gain and we focus on 
outliers where this difference is larger than 10 years in absolute magnitude. Countries that jump 
between regimes shown in table 2 tend to be near the borderline between regimes to begin with. 
However, outliers in absolute magnitude of their performance come from across the distribution. 
Bhutan, Western Sahara and Nepal appear to be in mortality trap but had very large gains in life 
expectancy, though not sufficient to move them out of the trap. On the other hand Indonesia, 23 
 
Viet Nam and Oman are all once again outliers with large gains in life expectancy relative to 
what we would predict given our model.  Swaziland, Zambia, Lesotho, Uganda, Kenya, South 
Africa, Congo, Botswana and Zimbabwe all had life expectancy gains more than 10 years lower 
than our model predicts, which can explained by HIV/AIDS. The former Soviet Union also 
performed very poorly relative to our prediction, though in this case the causes are related to the 
collapse of employment, stress, and alcoholism (Shkolnikov et al. 2001).  
 
6. Determinants of Health  
There are a number of factors that lead to health improvements. The proximal determinants are 
factors that affect nutrition and the disease environment, together with preventive and curative 
medical interventions.  Improvements in nutrition strengthen the immune system and reduce 
susceptibility to disease. Access to clean water and sanitation can reduce the transmission of 
fecal contamination and the spread of infection.  Preventive interventions, such as vaccination, 
can immunize against disease. Medical treatment can cure disease. The epidemiological 
transition sets out a model where countries transition from a high burden of infectious disease to 
a greater burden of non-infectious disease, though countries can have a dual burden with non-
infectious diseases becoming prevalent while the infectious diseases have not been eliminated. 
There is a debate about the relative importance of the different factors that affect health. 
Fogel (2004) emphasizes the historical effect of improving nutrition while Preston (1975) and 
Deaton (2006) put more weight technological progress and new health interventions. There is 
evidence of the on public health measures such as clean water and sanitation in cities (Cultler 
and Miller, 2005), as well as a role for medical treatment in modern populations (Cutler and 24 
 
McClellan, 2001). The relative importance of these mechanisms clearly varies in different times 
and places, and the interaction between them makes a precise accounting difficult.  
An alternative to looking at these proximal determinants of health is to look at more 
distal determinants. We can think of health as being determined my income and education 
(Lleras-Muney, 2005).  Income provides the means to purchase nutrition and health inputs and so 
leads to better health. Although there is a strong case for the direct effect of income on health 
due to nutrition and health interventions becoming more affordable, it may be that income is also 
acting as a proxy for a wider measure of socioeconomic status and development and that the 
causal effect is due to other mechanisms. Another possible explanation for the link between 
income and health at the individual level is that it is relative, and not absolute, income that 
matters (Lynch et al. 2000, Martikaien et al. 2002, Marmot and Wilkinson 2001, Marmot 2002). 
A low position in the social hierarchy may induce psychosocial stress that is linked to increased 
behaviors that put people at risk of ill health and to physiological reactions in the immune system 
that directly lead to worse health. The relative income hypothesis suggests that inequality has a 
direct negative effect on health but the evidence for such a direct effect is contested (Deaton, 
2002, 2003) 
Preston (1975) showed that, across countries, life expected was correlated with income 
per capita, but that the relationship changes over time. In Figure 12 we plot Preston curves for 
1970 and 2005. We fit linear relationship between log income per capita and life expectancy in 
each year. We have put GDP per capita on a log scale to see the relationship more clearly
4
                                                           
4 There are a small number of countries that have very high incomes but relatively low life expectancies that do not 
seem to fit the usual relationship. These are oil producing countries. Note that their 1970 real GDP per capita is 
exceptionally high because their oil production is valued at 2005 prices (not 1970 prices).    
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is an upward slope to the relationship, with life expectancy being higher in countries with higher 
income per capita. However the relationship changes over time. For a country with a fixed level 
of income per capita, life expectancy in 2005 will on average be about eight years higher than in 
1970. Preston showed that about three quarters of life expectancy increase can be explained by 
the upward movement of the curve, and about one quarter by countries getting richer and moving 
along the curve.      
  The curvature of the relationship between income and health (implicit in our use of log 
income on the x axis in figure 12) suggests that a policy of redistributing income from the rich to 
the poor will improve average health outcomes since the gains in health of those with low 
incomes will outweigh the losses of those with high incomes. The World Health Organization’s 
Commission on Social Determinants of Health (2008) argues that in order to improve health 
inequalities countries and global institutions need to tackle the inequitable distribution of money, 
power, and resources in the world. The U.K government recently commissioned a report on 
effective evidence-based strategies for reducing health inequalities in England from 2010. The 
resulting Marmet Review (2010) advocates a policy of focusing on investment in childhood 
health and education, and reducing the gradient in living standards through a more progressive 
tax system. However, this policy prescription depends on the relationship being causal rather 
than income merely acting as a proxy for some broader notion of socio-economic status, and 
needs to be balanced against the negative incentive effects of redistributive taxation (Deaton, 
2003) 
The upward slope of the Preston curve gave birth to the idea that increased wealth leads 
causally to increased health. Pritchett and Summers (1996) argue that focusing on economic 26 
 
growth in developing countries will lead directly to reductions in infant mortality rates and 
improvements in life expectancy, as they see improved health as a by-product of higher income 
levels. The problem with this argument is that, as shown by Preston (1995), most of the health 
gains we have experienced have been due to improvements in health at each level of income, 
which is likely to be due to technological progress, i.e., using resources more effectively. Bloom 
and Canning (2001) found that before 1870 health in rich and poor countries was very similar, 
but after 1870 health improved in rich countries whereas improvements in poor countries only 
began after 1930. This is consistent with the view that technological advances are employed first 
in rich countries before eventually diffusing to poorer societies.  
Relatively little work has been done that focuses directly on the contribution of 
technological progress to population health, though Jamison, Sandbu, and Wang (2001) identify 
technological progress in health and study its determinants while Cutler, Deaton, and Lleras-
Muney (2006) conclude that scientific and technical advance is “the ultimate determinant of 
health”. A further argument against focusing on income growth as a method of alleviating health 
burdens is that although income levels and population health are closely linked, the connection 
between periods of economic growth and periods of improvement in population health is very 
weak, suggesting that if the relationship is causal it has long and variable lags (Easterly 1999). 
Although rising incomes mean that society has greater resources, these resources are not always 
applied to health. 
  Preston’s diagram has been taken by many to imply a causal link from wealth to health. 
In the years since the paper was written, however, the possibility that the link could also run in 
the reverse direction, from improved health to higher incomes, has been investigated. Healthier 27 
 
workers are more productive, and longer life spans create incentives to invest in schooling and 
save for retirement (Bloom and Canning, 2000). In addition, , healthier children are likely to 
attend school more regularly, more easily absorb knowledge while in school, and increase their 
cognitive ability.  The health-to-wealth idea has important policy implications because it 
suggests that health is a cause as well as a consequence of income growth, and can be a powerful 
instrument of economic development and poverty reduction. Micro-level studies such as those 
reported by Strauss and Thomas (1998) and Schultz (2005) support this thesis, although work to 
estimate the size of the effect of health on wealth at the aggregate level is still ongoing 
(Commission on Macroeconomics and Health, 2001, Bloom Canning and Sevilla, 2004, 
Acemoglu and Johnson, 2006). 
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Models of Conditional Convergence in Life Expectancy 
 
Dependent variable, change in life expectancy 1970-2005. 
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Afghanistan  35.0  7.9  16.4  26.4  1.00  1.00 
Sierra Leone  36.0  10.4  15.7  25.9  1.00  1.00 
Angola  37.0  8.5  14.9  25.4  1.00  1.00 
Guinea-Bissau  37.2  9.8  14.7  25.3  1.00  1.00 
Mali  37.5  9.8  14.5  25.1  0.99  1.00 
Niger  38.1  11.5  14.0  24.7  0.99  1.00 
Yemen  38.2  23.3  13.9  24.7  0.99  0.98 
Guinea  39.2  17.1  13.2  24.2  0.99  1.00 
Mozambique  39.2  8.4  13.2  24.1  0.99  1.00 
Timor-Leste  39.5  20.2  12.9  24.0  0.98  0.99 
Equatorial Guinea  39.8  9.5  12.8  23.9  0.98  1.00 
Somalia  40.1  9.5  12.5  23.7  0.98  1.00 
Nigeria  40.4  6.9  12.3  23.5  0.98  1.00 
Gambia  40.6  14.6  12.1  23.4  0.97  1.00 
Malawi  40.6  10.5  12.1  23.4  0.97  1.00 
Bhutan  40.6  24.2  12.1  23.4  0.97  0.86 
Burkina Faso  41.5  10.6  11.4  22.9  0.96  1.00 
Central African 
Republic  42.0  4.2  11.1  22.7  0.95  1.00 
Western Sahara  42.0  22.9  11.0  22.6  0.95  0.77 

























   
Nepal  42.6  22.6  10.6  22.3  0.94  0.71 
thiopia  42.9  10.8  10.3  22.1  0.93  1.00 
Djibouti  43.2  11.2  10.1  22.0  0.92  1.00 
Papua New Guinea  43.3  16.7  10.1  21.9  0.92  0.96 
Eritrea  43.3  15.1  10.0  21.9  0.92  0.99 
Cambodia  43.6  15.8  9.8  21.8  0.91  0.98 
Burundi  43.8  5.4  9.7  21.7  0.90  1.00 
Congo (DR)  43.8  3.8  9.6  21.6  0.90  1.00 
Madagascar  43.8  15.1  9.6  21.6  0.90  0.98 
Bangladesh  44.0  20.6  9.5  21.5  0.89  0.65 
Rwanda  44.4  4.0  9.2  21.3  0.88  1.00 
Liberia  44.4  12.6  9.2  21.3  0.88  1.00 
Chad  44.6  3.9  9.0  21.2  0.87  1.00 
Benin  45.5  14.7  8.4  20.8  0.82  0.95 
Bolivia  45.8  18.9  8.2  20.6  0.81  0.54 
Cameroon  45.9  4.7  8.0  20.5  0.80  1.00 
Lao PDR  46.0  17.6  8.0  20.4  0.80  0.66 
Sudan  46.4  10.9  7.7  20.3  0.77  1.00 
Gabon  46.7  12.8  7.5  20.1  0.75  1.00 
Tanzania   46.7  7.0  7.5  20.1  0.75  0.97 

























   
Haiti  47.2  13.2  7.1  19.8  0.72  0.94 
Indonesia  47.6  22.1  6.8  19.6  0.69  0.14 
Mauritania  47.7  8.8  6.7  19.6  0.69  1.00 
Comoros  47.7  16.4  6.7  19.5  0.69  0.54 
Swaziland  48.0  -3.0  6.4  19.4  0.66  1.00 
India  48.8  13.9  5.8  18.9  0.60  0.73 
Viet Nam  48.8  25.0  5.8  18.9  0.60  0.10 
Ghana  48.9  7.7  5.8  18.9  0.60  1.00 
Zambia  49.0  -6.1  5.7  18.8  0.59  1.00 
Lesotho  49.0  -4.2  5.7  18.8  0.59  1.00 
Togo  49.3  12.1  5.5  18.7  0.56  0.88 
Oman  49.5  25.5  5.3  18.6  0.55  0.08 
Uganda  49.8  0.4  5.0  18.4  0.52  1.00 
Maldives  49.9  20.1  5.0  18.4  0.52  0.07 
Egypt  50.5  19.1  4.6  18.0  0.47  0.06 
Libyan Arab 
Jamahiriya  51.3  22.0  3.9  17.6  0.40  0.03 
Myanmar  51.5  9.1  3.8  17.5  0.39  0.95 
Morocco  51.6  18.9  3.7  17.4  0.38  0.04 
Saudi Arabia  51.8  20.4  3.5  17.3  0.36  0.03 
Guatemala  52.1  17.6  3.4  17.2  0.34  0.04 

























   
Honduras  52.4  19.1  3.1  17.0  0.32  0.02 
Vanuatu  52.5  16.8  3.0  16.9  0.31  0.04 
Namibia  52.6  6.1  3.0  16.9  0.31  0.99 
Mongolia  52.6  12.9  2.9  16.9  0.31  0.23 
South Africa  52.8  -1.0  2.8  16.8  0.29  1.00 
Algeria  52.9  18.8  2.7  16.7  0.28  0.02 
Peru  53.5  19.0  2.3  16.4  0.24  0.01 
Nicaragua  53.6  18.3  2.1  16.3  0.24  0.01 
Tunisia  53.7  19.8  2.1  16.3  0.23  0.01 
Iran (IR)  53.9  16.7  1.9  16.2  0.22  0.02 
Jordan  54.0  17.9  1.9  16.1  0.21  0.01 
Occupied Palestinian 
Territories  54.0  18.9  1.8  16.1  0.21  0.01 
Pakistan  54.2  11.3  1.7  16.0  0.20  0.21 
Solomon Islands  54.2  10.6  1.7  16.0  0.20  0.31 
Congo  54.4  -1.1  1.5  15.9  0.19  1.00 
Botswana  54.6  -3.6  1.4  15.8  0.18  1.00 
Zimbabwe  54.9  -13.2  1.2  15.6  0.16  1.00 
Samoa  54.9  15.9  1.2  15.6  0.16  0.01 
Syrian Arab Republic  55.4  18.2  0.8  15.3  0.14  0.01 
Sao Tome and Principe 55.5  9.4  0.7  15.3  0.14  0.28 

























   
Cape Verde  56.5  14.0  0.0  14.8  0.10  0.01 
El Salvador  56.6  14.2  -0.1  14.7  0.09  0.01 
Philippines  57.2  13.8  -0.6  14.4  0.07  0.01 
Ecuador  57.8  16.9  -1.0  14.1  0.06  0.00 
Iraq  58.0  10.5  -1.2  13.9  0.05  0.02 
Dominican Republic  58.4  13.7  -1.5  13.7  0.05  0.00 
Brazil  58.6  13.1  -1.6  13.6  0.04  0.00 
Korea (Republic of)  59.2  19.4  -2.1  13.3  0.03  0.00 
Thailand  59.4  9.0  -2.3  13.2  0.03  0.02 
Fiji  59.6  8.7  -2.4  13.1  0.03  0.02 
Guyana  59.7  5.8  -2.5  13.0  0.03  0.15 
French Polynesia  60.1  13.6  -2.8  12.8  0.02  0.00 
Qatar  60.5  14.5  -3.1  12.6  0.02  0.00 
New Caledonia  60.5  15.2  -3.1  12.6  0.02  0.00 
United Arab Emirates  60.5  16.5  -3.1  12.6  0.02  0.00 
St. Vincent- Grenadines 60.6  10.4  -3.2  12.5  0.02  0.00 
Colombia  60.9  11.4  -3.4  12.4  0.01  0.00 
Malaysia  61.3  12.4  -3.7  12.1  0.01  0.00 
Mexico  61.4  14.1  -3.8  12.1  0.01  0.00 
Micronesia   61.6  6.4  -4.0  12.0  0.01  0.01 

























   
China  62.0  10.6  -4.2  11.8  0.01  0.00 
Korea (DPR)  62.0  4.8  -4.2  11.8  0.01  0.04 
Chile  62.0  16.2  -4.3  11.8  0.01  0.00 
Mauritius  62.2  9.8  -4.4  11.7  0.01  0.00 
Réunion  62.4  13.7  -4.6  11.5  0.01  0.00 
Sri Lanka  62.6  11.1  -4.7  11.5  0.01  0.00 
Suriname  63.3  5.1  -5.3  11.0  0.00  0.01 
Saint Lucia  63.9  9.2  -5.7  10.7  0.00  0.00 
Grenada  64.3  10.6  -6.1  10.5  0.00  0.00 
Lebanon  64.7  6.8  -6.3  10.3  0.00  0.00 
Tonga  65.0  6.5  -6.5  10.2  0.00  0.00 
Venezuela   65.0  8.3  -6.6  10.1  0.00  0.00 
French Guiana  65.2  10.3  -6.7  10.0  0.00  0.00 
Panama  65.4  9.8  -6.8  9.9  0.00  0.00 
Paraguay  65.4  5.9  -6.9  9.9  0.00  0.00 
Guam  65.6  9.5  -7.0  9.8  0.00  0.00 
Trinidad and Tobago  65.6  3.1  -7.0  9.8  0.00  0.00 
Macao, China (SAR)  65.8  14.2  -7.2  9.7  0.00  0.00 
Bahamas  66.2  6.2  -7.5  9.5  0.00  0.00 
Kuwait  66.4  10.9  -7.6  9.4  0.00  0.00 

























   
Argentina  66.6  8.2  -7.8  9.3  0.00  0.00 
Brunei Darussalam  66.7  10.1  -7.8  9.2  0.00  0.00 
Guadeloupe  66.7  12.0  -7.9  9.2  0.00  0.00 
Costa Rica  66.8  11.6  -8.0  9.1  0.00  0.00 
Albania  67.0  9.2  -8.1  9.1  0.00  0.00 
Portugal  67.1  11.1  -8.1  9.0  0.00  0.00 
US Virgin Islands  67.7  10.8  -8.6  8.7  0.00  0.00 
Yugoslavia  67.9  6.7  -8.7  8.6  0.00  0.00 
Martinique  67.9  11.3  -8.8  8.5  0.00  0.00 
Romania  68.0  4.0  -8.9  8.5  0.00  0.00 
Jamaica  68.3  3.0  -9.1  8.3  0.00  0.00 
Former Soviet Union  68.5  -1.9  -9.2  8.2  0.00  0.01 
Barbados  68.5  8.0  -9.2  8.2  0.00  0.00 
Uruguay  68.7  7.0  -9.4  8.1  0.00  0.00 
Singapore  68.8  10.8  -9.5  8.1  0.00  0.00 
Aruba  69.2  5.1  -9.7  7.9  0.00  0.00 
Hungary  69.3  3.6  -9.9  7.8  0.00  0.00 
Netherlands Antilles  69.4  6.4  -9.9  7.8  0.00  0.00 
Cuba  69.9  8.1  -10.3  7.5  0.00  0.00 
Malta  70.0  9.3  -10.4  7.4  0.00  0.00 

























   
Finland  70.1  8.9  -10.5  7.4  0.00  0.00 
Austria  70.1  9.3  -10.5  7.3  0.00  0.00 
Luxembourg  70.2  8.7  -10.5  7.3  0.00  0.00 
Poland  70.2  4.9  -10.6  7.3  0.00  0.00 
Cyprus  70.8  8.6  -11.0  7.0  0.00  0.00 
Germany  70.8  8.5  -11.0  7.0  0.00  0.00 
United States  70.8  7.9  -11.0  7.0  0.00  0.00 
Bulgaria  71.1  1.6  -11.2  6.8  0.00  0.00 
Hong Kong, China 
(SAR)  71.1  10.9  -11.2  6.8  0.00  0.00 
Belgium  71.1  7.8  -11.2  6.8  0.00  0.00 
Australia  71.1  9.9  -11.3  6.8  0.00  0.00 
Ireland  71.2  7.7  -11.3  6.8  0.00  0.00 
Israel  71.2  9.1  -11.3  6.8  0.00  0.00 
New Zealand  71.4  8.4  -11.5  6.6  0.00  0.00 
Italy  71.5  9.3  -11.5  6.6  0.00  0.00 
Puerto Rico  71.7  6.8  -11.6  6.5  0.00  0.00 
United Kingdom  71.7  7.3  -11.7  6.5  0.00  0.00 
Greece  71.7  7.0  -11.7  6.5  0.00  0.00 
France  71.8  8.6  -11.8  6.4  0.00  0.00 
Japan  72.2  10.2  -12.1  6.2  0.00  0.00 

























   
Canada  72.5  7.7  -12.3  6.0  0.00  0.00 
Switzerland  72.9  8.4  -12.6  5.8  0.00  0.00 
Denmark  73.2  4.6  -12.9  5.6  0.00  0.00 
Netherlands  73.7  5.6  -13.2  5.4  0.00  0.00 
Iceland  73.7  7.8  -13.2  5.4  0.00  0.00 
Norway  74.1  5.9  -13.5  5.2  0.00  0.00 





















Afghanistan  35.0  7.9  16.4  -8.6 
Sierra Leone  36.0  10.4  15.7  -5.3 
Angola  37.0  8.5  14.9  -6.4 
Guinea-Bissau  37.2  9.8  14.7  -5.0 
Mali  37.5  9.8  14.6  -4.7 
Niger  38.1  11.5  14.1  -2.5 
Yemen  38.2  23.3  14.0  9.3 
Guinea  39.2  17.1  13.3  3.7 
Mozambique  39.2  8.4  13.3  -4.9 
Timor-Leste  39.5  20.2  13.1  7.1 
Equatorial Guinea  39.8  9.5  13.0  -3.5 
Somalia  40.1  9.5  12.7  -3.2 
Nigeria  40.4  6.9  12.6  -5.7 
Gambia  40.6  14.6  12.4  2.2 
Malawi  40.6  10.5  12.4  -1.9 
Bhutan  40.6  24.2  12.4  11.8 
Burkina Faso  41.5  10.6  11.9  -1.3 
Central African Republic  42.0  4.2  11.7  -7.5 
Western Sahara  42.0  22.9  11.6  11.3 
Senegal  42.6  12.3  11.4  1.0 


















Ethiopia  42.9  10.8  11.2  -0.3 
Djibouti  43.2  11.2  11.1  0.2 
Papua New Guinea  43.3  16.7  11.1  5.6 
Eritrea  43.3  15.1  11.0  4.1 
Cambodia  43.6  15.8  10.9  4.9 
Burundi  43.8  5.4  10.9  -5.5 
Congo (Democratic Republic of the)  43.8  3.8  10.8  -7.0 
Madagascar  43.8  15.1  10.8  4.3 
Bangladesh  44.0  20.6  10.8  9.8 
Rwanda  44.4  4.0  10.7  -6.7 
Liberia  44.4  12.6  10.7  1.9 
Chad  44.6  3.9  10.6  -6.7 
Benin  45.5  14.7  10.6  4.1 
Bolivia  45.8  18.9  10.6  8.3 
Cameroon  45.9  4.7  10.5  -5.8 
Lao People's Democratic Republic  46.0  17.6  10.5  7.1 
Sudan  46.4  10.9  10.6  0.3 
Gabon  46.7  12.8  10.6  2.2 
Tanzania (United Republic of)  46.7  7.0  10.6  -3.6 
Côte d'Ivoire  47.0  9.0  10.6  -1.6 
Haiti  47.2  13.2  10.6  2.6 


















Mauritania  47.7  8.8  10.7  -2.0 
Comoros  47.7  16.4  10.7  5.6 
Swaziland  48.0  -3.0  10.8  -13.8 
India  48.8  13.9  11.0  2.9 
Viet Nam  48.8  25.0  11.0  14.0 
Ghana  48.9  7.7  11.1  -3.5 
Zambia  49.0  -6.1  11.1  -17.2 
Lesotho  49.0  -4.2  11.1  -15.3 
Togo  49.3  12.1  11.3  0.8 
Oman  49.5  25.5  11.3  14.2 
Uganda  49.8  0.4  11.4  -11.0 
Maldives  49.9  20.1  11.5  8.6 
Egypt  50.5  19.1  11.7  7.3 
Libyan Arab Jamahiriya  51.3  22.0  12.1  9.9 
Myanmar  51.5  9.1  12.2  -3.1 
Morocco  51.6  18.9  12.2  6.7 
Saudi Arabia  51.8  20.4  12.3  8.1 
Guatemala  52.1  17.6  12.5  5.1 
Kenya  52.2  0.3  12.5  -12.2 
Honduras  52.4  19.1  12.6  6.5 
Vanuatu  52.5  16.8  12.6  4.2 


















Mongolia  52.6  12.9  12.6  0.3 
South Africa  52.8  -1.0  12.7  -13.7 
Algeria  52.9  18.8  12.7  6.0 
Peru  53.5  19.0  13.0  6.0 
Nicaragua  53.6  18.3  12.9  5.4 
Tunisia  53.7  19.8  13.0  6.8 
Iran (Islamic Republic of)  53.9  16.7  13.1  3.7 
Jordan  54.0  17.9  13.1  4.9 
Occupied Palestinian Territories  54.0  18.9  13.0  5.9 
Pakistan  54.2  11.3  13.1  -1.8 
Solomon Islands  54.2  10.6  13.1  -2.5 
Congo  54.4  -1.1  13.2  -14.3 
Botswana  54.6  -3.6  13.2  -16.8 
Zimbabwe  54.9  -13.2  13.2  -26.4 
Samoa  54.9  15.9  13.2  2.7 
Syrian Arab Republic  55.4  18.2  13.3  5.0 
Sao Tome and Principe  55.5  9.4  13.3  -3.9 
Turkey  55.7  15.7  13.3  2.4 
Cape Verde  56.5  14.0  13.4  0.7 
El Salvador  56.6  14.2  13.3  0.8 
Philippines  57.2  13.8  13.3  0.5 


















Iraq  58.0  10.5  13.1  -2.6 
Dominican Republic  58.4  13.7  13.0  0.7 
Brazil  58.6  13.1  13.0  0.1 
Korea (Republic of)  59.2  19.4  12.8  6.6 
Thailand  59.4  9.0  12.7  -3.7 
Fiji  59.6  8.7  12.7  -4.0 
Guyana  59.7  5.8  12.6  -6.8 
French Polynesia  60.1  13.6  12.5  1.1 
Qatar  60.5  14.5  12.3  2.2 
New Caledonia  60.5  15.2  12.3  2.8 
United Arab Emirates  60.5  16.5  12.3  4.2 
Saint Vincent and the Grenadines  60.6  10.4  12.2  -1.8 
Colombia  60.9  11.4  12.2  -0.8 
Malaysia  61.3  12.4  11.9  0.4 
Mexico  61.4  14.1  11.9  2.2 
Micronesia (Federated States of)  61.6  6.4  11.8  -5.4 
Bahrain  61.7  13.6  11.8  1.8 
China  62.0  10.6  11.7  -1.1 
Korea (Democratic People's Rep. of)  62.0  4.8  11.7  -6.8 
Chile  62.0  16.2  11.7  4.5 
Mauritius  62.2  9.8  11.6  -1.7 


















Sri Lanka  62.6  11.1  11.4  -0.3 
Suriname  63.3  5.1  10.9  -5.8 
Saint Lucia  63.9  9.2  10.7  -1.4 
Grenada  64.3  10.6  10.5  0.1 
Lebanon  64.7  6.8  10.3  -3.5 
Tonga  65.0  6.5  10.2  -3.7 
Venezuela (Bolivarian Republic of)  65.0  8.3  10.1  -1.8 
French Guiana  65.2  10.3  10.0  0.3 
Panama  65.4  9.8  9.9  -0.1 
Paraguay  65.4  5.9  9.9  -4.0 
Guam  65.6  9.5  9.8  -0.3 
Trinidad and Tobago  65.6  3.1  9.8  -6.7 
Macao, China (SAR)  65.8  14.2  9.7  4.5 
Bahamas  66.2  6.2  9.5  -3.3 
Kuwait  66.4  10.9  9.4  1.5 
Belize  66.4  9.0  9.4  -0.4 
Argentina  66.6  8.2  9.3  -1.1 
Brunei Darussalam  66.7  10.1  9.2  0.9 
Guadeloupe  66.7  12.0  9.2  2.8 
Costa Rica  66.8  11.6  9.1  2.5 
Albania  67.0  9.2  9.1  0.1 


















United States Virgin Islands  67.7  10.8  8.7  2.1 
Yugoslavia  67.9  6.7  8.6  -1.9 
Martinique  67.9  11.3  8.5  2.8 
Romania  68.0  4.0  8.5  -4.5 
Jamaica  68.3  3.0  8.3  -5.3 
Former Soviet Union  68.5  -1.9  8.2  -10.0 
Barbados  68.5  8.0  8.2  -0.2 
Uruguay  68.7  7.0  8.1  -1.1 
Singapore  68.8  10.8  8.1  2.7 
Aruba  69.2  5.1  7.9  -2.8 
Hungary  69.3  3.6  7.8  -4.2 
Netherlands Antilles  69.4  6.4  7.8  -1.4 
Cuba  69.9  8.1  7.5  0.6 
Malta  70.0  9.3  7.4  1.9 
Czechoslovakia  70.1  5.3  7.4  -2.1 
Finland  70.1  8.9  7.4  1.5 
Austria  70.1  9.3  7.3  2.0 
Luxembourg  70.2  8.7  7.3  1.4 
Poland  70.2  4.9  7.3  -2.4 
Cyprus  70.8  8.6  7.0  1.6 
Germany  70.8  8.5  7.0  1.5 


















Bulgaria  71.1  1.6  6.8  -5.2 
Hong Kong, China (SAR)  71.1  10.9  6.8  4.1 
Belgium  71.1  7.8  6.8  1.0 
Australia  71.1  9.9  6.8  3.1 
Ireland  71.2  7.7  6.8  0.9 
Israel  71.2  9.1  6.8  2.3 
New Zealand  71.4  8.4  6.6  1.8 
Italy  71.5  9.3  6.6  2.7 
Puerto Rico  71.7  6.8  6.5  0.3 
United Kingdom  71.7  7.3  6.5  0.8 
Greece  71.7  7.0  6.5  0.5 
France  71.8  8.6  6.4  2.2 
Japan  72.2  10.2  6.2  4.0 
Spain  72.2  8.1  6.2  1.9 
Canada  72.5  7.7  6.0  1.7 
Switzerland  72.9  8.4  5.8  2.6 
Denmark  73.2  4.6  5.6  -1.0 
Netherlands  73.7  5.6  5.4  0.2 
Iceland  73.7  7.8  5.4  2.4 
Norway  74.1  5.9  5.2  0.7 
Sweden  74.4  6.1  5.0  1.1 
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National Life Expectancy and Expected 




















































































































































































































































































































Expected Change in Life Expectancy 1970-2005: Two Regme Model